Review & Outlook: Improvised Explosive Device Tax - WSJ.com
The 2.3% levy applies to the sale of everything from cardiac defibrillators to artificial joints to MRI scanners.
The device tax is supposed to raise $28.5 billion from 2013 to 2022, and it is especially harmful because it applies to gross sales, not profits.
Companies at make-or-break margins could be taxed out of existence, especially in an intensely competitive industry where four of five businesses are start-ups or midsized.
No comments:
Post a Comment